![Susan M. Catalano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan M. Catalano
Nessuna posizione attualmente
Patrimonio netto: 166 $ in data 31/05/2024
Profilo
Susan M.
Catalano is the founder of Cognition Therapeutics, Inc. which was founded in 2007.
She held the title of Director & Chief Scientific Officer from 2011 to 2022.
Dr. Catalano's former jobs include Director-Discovery Biology at Acumen Pharmaceuticals, Inc. and Senior Scientist at Rigel Pharmaceuticals, Inc. She earned a doctorate degree from the University of California, Irvine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
WEWORK INC. CLASS A
0.00% | 20/03/2023 | 1 472 ( 0.00% ) | 166 $ | 31/05/2024 |
Precedenti posizioni note di Susan M. Catalano
Società | Posizione | Fine |
---|---|---|
COGNITION THERAPEUTICS, INC. | Fondatore | 01/02/2022 |
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
ACUMEN PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Susan M. Catalano
University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
COGNITION THERAPEUTICS, INC. | Health Technology |
ACUMEN PHARMACEUTICALS, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
- Borsa valori
- Insiders
- Susan M. Catalano